Product Name:Galantamine hydrobromide

IUPAC Name:(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraen-14-ol hydrobromide

CAS:1953-04-4
Molecular Formula:C17H22BrNO3
Purity:99%
Catalog Number:CM110074
Molecular Weight:368.27

Packing Unit Available Stock Price($) Quantity
CM110074-100mg 3-4 Weeks ȋŸş
CM110074-250mg 4-5 Weeks œȤȤ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1953-04-4
Molecular Formula:C17H22BrNO3
Melting Point:-
Smiles Code:O(C)C1=C2C=3[C@]4([C@@](O2)(C[C@@H](O)C=C4)[H])CCN(C)CC3C=C1.Br
Density:
Catalog Number:CM110074
Molecular Weight:368.27
Boiling Point:
MDL No:MFCD00067672
Storage:Store at 2-8 ℃

Column Infos

ZUNVEYL
Alpha Cognition announced that the FDA has granted approval for ZUNVEYL® (benzgalantamine) previously known as ALPHA-1062, for the treatment of mild-to-moderate Alzheimer’s disease. ZUNVEYL, a prodrug of AD treatment galantamine and an acetylcholinesterase inhibitor (AChEI), is postulated to exert its therapeutic effect by preventing the breakdown of acetylcholine, the important brain neurotransmitter involved in memory, motivation, and attention functions. The approval of ZUNVEYL is a pivotal moment in the fight against Alzheimer’s disease as it is only the second oral AD treatment to be approved in more than a decade.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.